Jeremy Green - Net Worth and Insider Trading

Over the past 18 months, Jeremy Green made no insider transaction in Shattuck Labs Inc (STTK). Other recent insider transactions involving Shattuck Labs Inc (STTK) include a net purchase of 50,900 shares made by Taylor Schreiber , a net sale of 25,000 shares made by Andrew R Neill , and a net sale of 16,004 shares made by Stephen Stout .

In summary, during the past 3 months, insiders sold 0 shares of Shattuck Labs Inc (STTK) in total and bought 36,500 shares, with a net purchase of 36,500 shares. During the past 18 months, 41,004 shares of Shattuck Labs Inc (STTK) were sold and 59,316 shares were bought by its insiders, resulting in a net purchase of 18,312 shares.

Shattuck Labs Inc (STTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in IGM Biosciences Inc (IGMS). Other recent insider transactions involving IGM Biosciences Inc (IGMS) include a net sale of 37,229 shares made by Fred Schwarzer , a net sale of 16,027 shares made by Bruce Keyt , and a net sale of 12,086 shares made by Lisa Lynn Decker .

In summary, during the past 3 months, insiders sold 11,288 shares of IGM Biosciences Inc (IGMS) in total and bought 0 shares, with a net sale of 11,288 shares. During the past 18 months, 192,234 shares of IGM Biosciences Inc (IGMS) were sold and 1,130,933 shares were bought by its insiders, resulting in a net purchase of 938,699 shares.

IGM Biosciences Inc (IGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 961,800 shares made by Bruce Booth , a net sale of 89,481 shares made by Jared Gollob , and a net sale of 20,000 shares made by Jeffrey W. Albers .

In summary, during the past 3 months, insiders sold 18,500 shares of Kymera Therapeutics Inc (KYMR) in total and bought 1 shares, with a net sale of 18,499 shares. During the past 18 months, 1,456,442 shares of Kymera Therapeutics Inc (KYMR) were sold and 414,106 shares were bought by its insiders, resulting in a net sale of 1,042,336 shares.

Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in AlloVir Inc (ALVR). Other recent insider transactions involving AlloVir Inc (ALVR) include a net sale of 182,774 shares made by Diana Brainard , a net sale of 63,842 shares made by Brett R Hagen , and a net sale of 76,956 shares made by Vikas Sinha .

In summary, during the past 3 months, insiders sold 31,263 shares of AlloVir Inc (ALVR) in total and bought 0 shares, with a net sale of 31,263 shares. During the past 18 months, 345,327 shares of AlloVir Inc (ALVR) were sold and 2,930,870 shares were bought by its insiders, resulting in a net purchase of 2,585,543 shares.

AlloVir Inc (ALVR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 74,985 shares made by Ted Yednock , a net purchase of 22,400 shares made by William H. Carson , and a net sale of 6,563 shares made by Jennifer Lew .

In summary, during the past 3 months, insiders sold 26,408 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 20,008 shares. During the past 18 months, 92,392 shares of Annexon Inc (ANNX) were sold and 672,400 shares were bought by its insiders, resulting in a net purchase of 580,008 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 67,327 shares made by Christine Ring , a net sale of 82,022 shares made by Houte Hans Van , and a net sale of 14,703 shares made by Gwenn Hansen .

In summary, during the past 3 months, insiders sold 70,553 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 70,553 shares. During the past 18 months, 164,052 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 164,052 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .

In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,978,847 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 18,777 shares made by Dulac Edward J Iii , a net sale of 4,725 shares made by Yuan Xu , and a net sale of 35,237 shares made by Cindy Tahl .

In summary, during the past 3 months, insiders sold 633 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 633 shares. During the past 18 months, 88,255 shares of Fate Therapeutics Inc (FATE) were sold and 44,630 shares were bought by its insiders, resulting in a net sale of 43,625 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Pliant Therapeutics Inc (PLRX). Other recent insider transactions involving Pliant Therapeutics Inc (PLRX) include a net sale of 72,542 shares made by Hans Hull , a net sale of 30,386 shares made by Mike Ouimette , and a net sale of 134,581 shares made by Bernard Coulie .

In summary, during the past 3 months, insiders sold 0 shares of Pliant Therapeutics Inc (PLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 322,907 shares of Pliant Therapeutics Inc (PLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,907 shares.

Pliant Therapeutics Inc (PLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp , and a net sale of 1,323 shares made by Sean Michael Smith .

In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 66 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 114,201 shares.

Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Beam Therapeutics Inc (BEAM). Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 16,081 shares made by Christine Bellon , a net sale of 198,102 shares made by John M. Evans , and a net sale of 28,776 shares made by Amy Simon .

In summary, during the past 3 months, insiders sold 111,784 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 111,784 shares. During the past 18 months, 1,362,433 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,362,433 shares.

Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net sale of 110,000 shares made by Gwendolyn Binder ,

In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110,000 shares of Cabaletta Bio Inc (CABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.

Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Alder BioPharmaceuticals Inc (ALDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alder BioPharmaceuticals Inc (ALDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alder BioPharmaceuticals Inc (ALDR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 3,900 shares made by Oren Gilad , a net purchase of 26,957 shares made by Bernd R. Seizinger , and a net purchase of 23,728 shares made by Marc Duey .

In summary, during the past 3 months, insiders sold 6,462 shares of Aprea Therapeutics Inc (APRE) in total and bought 42,590 shares, with a net purchase of 36,128 shares. During the past 18 months, 6,462 shares of Aprea Therapeutics Inc (APRE) were sold and 69,417 shares were bought by its insiders, resulting in a net purchase of 62,955 shares.

Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .

In summary, during the past 3 months, insiders sold 0 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.

Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Akero Therapeutics Inc (AKRO). Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 171,998 shares made by Jonathan Young , a net sale of 443,502 shares made by Andrew Cheng , and a net sale of 140,584 shares made by Catriona Yale .

In summary, during the past 3 months, insiders sold 478,023 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 478,023 shares. During the past 18 months, 1,227,763 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net purchase of 92,237 shares.

Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Stoke Therapeutics Inc (STOK). Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 124,116 shares made by Barry Ticho , a net sale of 18,022 shares made by Jonathan Allan , and a net sale of 56,616 shares made by Huw M. Nash .

In summary, during the past 3 months, insiders sold 1,957,500 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 1,957,500 shares. During the past 18 months, 5,793,870 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,793,870 shares.

Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in HOOKIPA Pharma Inc (HOOK). Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 27,000 shares made by Reinhard Kandera , and a net purchase of 20,000 shares made by Jorn Aldag .

In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 4,700 shares were bought by its insiders, resulting in a net purchase of 4,700 shares.

HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 25,200 shares made by John P. Schmid , a net purchase of 30,769 shares made by Shannon John Patrick Jr , and a net purchase of 28,000 shares made by Steven Pieper .

In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 8,800 shares, with a net purchase of 8,800 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 104,779 shares were bought by its insiders, resulting in a net purchase of 104,779 shares.

Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in TCR2 Therapeutics Inc (TCRR). Other recent insider transactions involving TCR2 Therapeutics Inc (TCRR) include a net purchase of 178,936 shares made by Kevin C Tang , a net sale of 70,170 shares made by Ansbert Gadicke , and a net sale of 70,170 shares made by Mpm Asset Management Llc .

In summary, during the past 3 months, insiders sold 0 shares of TCR2 Therapeutics Inc (TCRR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 140,340 shares of TCR2 Therapeutics Inc (TCRR) were sold and 178,936 shares were bought by its insiders, resulting in a net purchase of 38,596 shares.

TCR2 Therapeutics Inc (TCRR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Vapotherm Inc (VAPO). Other recent insider transactions involving Vapotherm Inc (VAPO) include a net purchase of 450,000 shares made by Joseph Army , a net purchase of 75,500 shares made by Anthony L. Arnerich , and a net sale of 17,500 shares made by James W Liken .

In summary, during the past 3 months, insiders sold 0 shares of Vapotherm Inc (VAPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,500 shares of Vapotherm Inc (VAPO) were sold and 263,000 shares were bought by its insiders, resulting in a net purchase of 245,500 shares.

Vapotherm Inc (VAPO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Gritstone Bio Inc (GRTSQ). Other recent insider transactions involving Gritstone Bio Inc (GRTSQ) include a net sale of 1,749 shares made by Vassiliki Economides , a net sale of 24,263 shares made by Andrew R Allen , and a net sale of 13,749 shares made by Erin Jones .

In summary, during the past 3 months, insiders sold 0 shares of Gritstone Bio Inc (GRTSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 74,769 shares of Gritstone Bio Inc (GRTSQ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 62,769 shares.

Gritstone Bio Inc (GRTSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Replimune Group Inc (REPL). Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 51,624 shares made by Pamela Esposito , a net sale of 30,332 shares made by Konstantinos Xynos , and a net sale of 41,467 shares made by Sushil Patel .

In summary, during the past 3 months, insiders sold 8,938 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 8,938 shares. During the past 18 months, 282,095 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 282,095 shares.

Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Allakos Inc (ALLK). Other recent insider transactions involving Allakos Inc (ALLK) include a net sale of 87,064 shares made by Harlan Baird Radford ,

In summary, during the past 3 months, insiders sold 0 shares of Allakos Inc (ALLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 87,064 shares of Allakos Inc (ALLK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 87,064 shares.

Allakos Inc (ALLK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Chee Conley .

In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 333,235 shares made by John F Crowley , a net sale of 224,861 shares made by Bradley L Campbell , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 22,500 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 22,500 shares. During the past 18 months, 795,880 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 795,880 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in MedAvail Holdings Inc (MDVLQ). Other recent insider transactions involving MedAvail Holdings Inc (MDVLQ) include a net sale of 303 shares made by Ramona Seabaugh ,

In summary, during the past 3 months, insiders sold 0 shares of MedAvail Holdings Inc (MDVLQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 303 shares of MedAvail Holdings Inc (MDVLQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 303 shares.

MedAvail Holdings Inc (MDVLQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Absci Corp (ABSI). Other recent insider transactions involving Absci Corp (ABSI) include a net sale of 3,100,000 shares made by Phoenix Venture Partners Ii Lp , a net purchase of 222,222 shares made by Redmile Group, Llc , and a net sale of 19,859 shares made by Zachariah Jonasson .

In summary, during the past 3 months, insiders sold 0 shares of Absci Corp (ABSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,119,859 shares of Absci Corp (ABSI) were sold and 222,222 shares were bought by its insiders, resulting in a net sale of 2,897,637 shares.

Absci Corp (ABSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 12,900 shares made by Dipal Doshi , a net sale of 56,124 shares made by Nathan J Dowden , and a net sale of 49,989 shares made by Kory James Wentworth .

In summary, during the past 3 months, insiders sold 37,284 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 37,284 shares. During the past 18 months, 188,553 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 143,185 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Augmedix Inc (AUGX). Other recent insider transactions involving Augmedix Inc (AUGX) include a net sale of 474,775 shares made by Ian Shakil , a net purchase of 7,646 shares made by Paul Ginocchio , and a net purchase of 1,500,000 shares made by Redmile Group, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Augmedix Inc (AUGX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 486,545 shares of Augmedix Inc (AUGX) were sold and 1,536,530 shares were bought by its insiders, resulting in a net purchase of 1,049,985 shares.

Augmedix Inc (AUGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Science 37 Holdings Inc (SNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Science 37 Holdings Inc (SNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Science 37 Holdings Inc (SNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Invivyd Inc (IVVD). Other recent insider transactions involving Invivyd Inc (IVVD) include a net sale of 5,000,000 shares made by Adimab, Llc , and a net sale of 112,381 shares made by Terrance Mcguire .

In summary, during the past 3 months, insiders sold 0 shares of Invivyd Inc (IVVD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,112,381 shares of Invivyd Inc (IVVD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,112,381 shares.

Invivyd Inc (IVVD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 1,800,000 shares made by Krishna Yeshwant , a net purchase of 76,000 shares made by Andrew D. Ashe , and a net sale of 1,514 shares made by Joan Nickerson .

In summary, during the past 3 months, insiders sold 0 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,068 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,932 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net sale of 6,880 shares made by Christopher Astle , a net purchase of 3,350,000 shares made by Ecor1 Capital, Llc , and a net sale of 23,904 shares made by Kenneth Galbraith .

In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,583 shares of Zymeworks Inc (ZYME) were sold and 3,350,000 shares were bought by its insiders, resulting in a net purchase of 3,309,417 shares.

Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Jeremy Green made no insider transaction in RayzeBio inc (RYZB). Other recent insider transactions involving RayzeBio inc (RYZB) include a net purchase of 2,777,778 shares made by Viking Global Investors Lp , and a net purchase of 472,222 shares made by Maha Katabi .

In summary, during the past 3 months, insiders sold 0 shares of RayzeBio inc (RYZB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RayzeBio inc (RYZB) were sold and 3,250,000 shares were bought by its insiders, resulting in a net purchase of 3,250,000 shares.

RayzeBio inc (RYZB)'s detailed insider trading history can be found in Insider Trading Tracker table.